Agilent Technologies (A) Total Non-Current Liabilities (2009 - 2026)
Agilent Technologies (A) posted quarterly Total Non-Current Liabilities of $5.4 billion for Q2 2026, down 0.73% year-over-year from $5.5 billion in Q2 2025, and up 0.61% quarter-over-quarter from $5.4 billion in Q1 2026.
Agilent Technologies (A) Total Non-Current Liabilities (2009 - 2026) Analysis & Trends
Agilent Technologies (A) has reported Total Non-Current Liabilities for 18 consecutive years, with $5.4 billion the latest figure, recorded in Q2 2026.
- In Q2 2026, Total Non-Current Liabilities fell 0.73% year-over-year to $5.4 billion; the TTM figure through Apr 2026 stood at $5.4 billion (down 0.73% YoY), while the FY2025 annual figure was $5.5 billion, up 2.85% from the prior year.
- Total Non-Current Liabilities advanced to $5.4 billion in Q2 2026 per A's latest filing, from $5.4 billion in the prior quarter.
- Across five years, Total Non-Current Liabilities topped out at $5.5 billion in Q4 2025 and bottomed at $4.4 billion in Q4 2023.
- Historically, Total Non-Current Liabilities has averaged $5.1 billion across 5 years, with a median of $5.3 billion in 2022.
- Annual changes were most pronounced in 2023 — Total Non-Current Liabilities decreased 13.93% — and 2024, when it gained 20.92%.
- Agilent Technologies' Total Non-Current Liabilities stood at $5.2 billion in 2022, then fell by 13.93% to $4.4 billion in 2023, then advanced by 20.92% to $5.4 billion in 2024, then climbed by 2.85% to $5.5 billion in 2025, then retreated by 1.38% to $5.4 billion in 2026.
- Business Quant data shows A's Total Non-Current Liabilities at $5.4 billion in Q2 2026, $5.4 billion in Q1 2026, and $5.5 billion in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 108.64 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 85.84 Bn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 715.49 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 5.45 Bn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 22.94 Bn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 542.10 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 6.36 Bn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 3.39 Bn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 9.19 Bn |
| 10 | Quest Diagnostics | 27.10 Bn | 26.47 Bn | 1.03 Bn | 15.88 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 5.45 Bn |
| Jan 31, 2026 | 5.41 Bn |
| Oct 31, 2025 | 5.52 Bn |
| Jul 31, 2025 | 5.36 Bn |
| Apr 30, 2025 | 5.49 Bn |
| Jan 31, 2025 | 5.34 Bn |
| Oct 31, 2024 | 5.37 Bn |
| Jul 31, 2024 | 4.62 Bn |
| Apr 30, 2024 | 4.64 Bn |
| Jan 31, 2024 | 4.76 Bn |
| Oct 31, 2023 | 4.44 Bn |
| Jul 31, 2023 | 5.11 Bn |
| Apr 30, 2023 | 5.00 Bn |
| Jan 31, 2023 | 5.31 Bn |
| Oct 31, 2022 | 5.16 Bn |
| Jul 31, 2022 | 5.33 Bn |
| Apr 30, 2022 | 5.27 Bn |
| Jan 31, 2022 | 5.08 Bn |
| Oct 31, 2021 | 5.23 Bn |
| Jul 31, 2021 | 5.44 Bn |